|
Robert Tutag was appointed to the Board in September 2005. Mr. Tutag is currently and since 1990 has been President of Unisource Inc. a privately held Boulder Colorado company which identifies and develops niche pharmaceutical products for generic and brand name pharmaceutical companies. From 1964 through 1982 Mr. Tutag was President and Chief Operating Officer of Tutag Corporation. In that capacity he developed and managed operations of Cord Laboratories one of the original generic pharmaceutical manufacturing companies in addition to founding and overseeing Geneva Generics a generic sales and distribution company which developed into one of the country’s premier companies in its industry. Both Cord Laboratories and Geneva Generics were acquired by Ciba-Geigy Corporation. During that time period Mr. Tutag also served as a Director of Geneva Generics and as Vice President of Sales and a Director of Tutag Pharmaceuticals a branded distribution company. From 1983 through 1989 Mr. Tutag was President and Chief Executive Officer of NBR Financial Inc. a multi-bank holding company in Boulder Colorado. Since 1977 until the present Mr. Tutag has also been editor of GMP Trends Inc. Boulder Colorado an informational newsletter that reviews FDA and GMP inspection reports (483’s) for the pharmaceutical and medical device industries. Mr. Tutag also served as interim president from 1999-2000 and was a director from 1997-2001 of the Bank of Cherry Creek in Boulder Colorado. He received a BBA and an MBA from the University of Michigan. | 